In an ATS 2017 International Conference first, respiratory health professionals and patients joined other conference attendees at a rally near the Capitol on Tuesday, May 23 to voice their concerns about recent policies that threaten to undermine many of the ATS's advocacy priorities including: research funding, tobacco regulation, affordable health care, and clean air. Also participating in the rally was US senators Edward Markey (D-MA) and Tom Carper (D-DE).
In a new study presented at the 2017 American Thoracic Society International Conference, adult asthma patients treated with bronchial thermoplasty (BT) had fewer severe exacerbations and were able to reduce their ER visits and hospitalizations in the two years following treatment.
University of Texas Medical Branch at Galveston scientists have unlocked mysteries of how the Ebola virus hampers the body's natural defenses to speed the rate of infection and its accompanying lethal disease, according to a new report in PLOS Pathogens. The study was conducted in collaboration with the University of Washington and The National Institute of Allergy and Infectious Diseases.
St. Jude Children's Research Hospital scientists have used a drug being developed to fight solid tumors to restore normal metabolism in flu-infected cells and reduce viral production without the threat of drug resistance.
Mothers are viewed negatively if their child hasn't been vaccinated, no matter the reason. But mothers who outright refuse to vaccinate their children are viewed in a harsher light compared to those who delay vaccines because of safety concerns or who aren't up to date due to time constraints.
A cancer drug for patients with certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study. The promising data from this pilot study could have greater implications for adults with food allergies.
Directly injecting a tumor with an agent that activates a natural, powerful tumor suppressor enhances the drug's capacity to attack the tumor both locally and where it spreads, scientists report in the journal Cancer Research.
Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment. With safe and effective treatments in short supply, scientists report in PNAS Early Edition discovery of an experimental treatment that targets an Achilles heel of activated immune cells -- killing them off and stopping autoimmune damage.
Scientists have shown how diesel fumes trigger respiratory reflexes which could potentially worsen underlying conditions, such as asthma.
Rutgers University-New Brunswick scientists have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks and improve the management of asthma and other respiratory diseases, preventing hospitalizations and deaths.